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As the world’s population ages in unprecedented numbers
andproportions,managementofthebasichealthneedsofan
older population is a key challenge [1]. Older age is unques-
tionably associated with increased vulnerability and suscep-
tibility to disease and disability [2]. Ageing is the major
independent risk factor for most diseases of the Western
world including atherosclerosis, cancer, and arthritis as well
as for the prototypical aging diseases such as dementia and
osteoporosis [3]. Despite this, our understanding of how old
age predisposes us to disease remains rudimentary [4].
A greater understanding of the ageing process will pro-
vide insight into the underlying causes of many diseases
a n do p e nu pn e wa v e n u e sf o rp r e v e n t i o na n dt h e r a p y .O u r
research into the underlying causes of ageing led us to exam-
ine the liver architecture in great detail. The age-related
decrease in liver function is substantial and very relevant for
systemic exposure to substrates implicated in disease patho-
genesis and ageing. In the past, the liver was considered to
be relatively unaﬀected by ageing and age-related diseases.
Functional changes, particularly related to impaired drug
metabolism (which is reduced by 40–50% in old age),
were attributed only to age-related reduction in blood
ﬂow and liver mass [5]. However, as such mechanisms are
unable to fully explain age-related impairment of hepatic
function and the systemic eﬀects of these changes, much
greater investigation into other hepatic factors such as liver
blood vessel ultrastructure, immune function, and gene and
protein expression is warranted.
This special issue brings together many of the current
areas of research in the liver and ageing. It details ﬁndings on
the systemic role of the liver in health, disease, and treatment
options in the setting of old age.
The ﬁrst paper in this issue addresses the very important
area of DNA repair in ageing in the liver. M. Lebel et al.
have written an eloquent review that thoroughly explores the
role of genetic instability in age-related loss of liver function.
The authors postulate that this is an area of great promise
in understanding and combating diminished liver function
with age.
S. J. Mitchell et al. question the evidence base for the
current prescribing guidelines for the common analgesic
paracetamol in older people in their manuscript, which
examines how poorly understood pharmacodynamics and
pharmacokineticsareintheolderperson.Betterunderstand-
ing is required to reduce the risks both of underdosing this
important analgesic and of causing accidental hepatotox-
icity.
D. L. Schmucker and H. Sanchez investigate the impaired
liver regeneration seen in older people and animal models
and conclude that the regenerative capacity of older liver
is not impaired, rather the rate of regeneration is reduced.
This conclusion has very important implications for the
contentiousissueof theuseof donor liversfromolderpeople
in liver transplantation.
A. Warren et al. present an ultrastructural study of the
liver in old age, with particular focus on the hepatic stellate
cell, a cell synonymous with ﬁbrotic liver changes in disease.
The study shows for the ﬁrst time that, while there is lipid
engorgement of the cells with ageing, there is no activation.
Smooth muscle actin expression, the hallmark of the hepatic
stellate cell dediﬀerentiation into a ﬁbroblast, is seen in many
chronic liver diseases but not in old age. This ﬁnding yet
again shows that ageing changes in the liver are distinct from
the pathological processes seen in disease states.2 Current Gerontology and Geriatrics Research
X. He et al. address the important issue of cancer therapy
in the older person and how liver-related changes drastically
aﬀect the eﬃcacy and toxicity of chemotherapy agents. Due
to comorbidities and poor functional status, older people
have generally been omitted from drug therapy trials in
this area. The authors argue that the key to increasing
treatment eﬃcacy and decreasing toxicity in this group is
tailoring treatment speciﬁcally to individuals with their age
and comorbidities foremost in their treatment plan.
Finally the paper by L. Gan et al. examines nonalcoholic
fatty liver disease (NAFLD) in ageing. NAFLD is the most
common liver disease today and most people diagnosed with
NAFLD are aged over 60 years. The authors point out that
“Advanced age is associated with disease severity and ﬁbrosis
progression; a relatively high proportion of individuals with
progressive forms of NAFLD develop cirrhosis by the time
they are in their 70s or beyond, although more data are
required on the exact risks.” The paper also presents some
management strategies for older people with NAFLD.
These articles present the state of knowledge of many
aspects of the liver in ageing. We would suggest that they
p u tf o r w a r dac o m p e l l i n ga r g u m e n tt h a tat h o r o u g hu n d e r -
standing of how the liver changes with age is important in
disease prevention, modulation, and treatment in the setting
of the older person.
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